Constant efforts are being made in the country to intensify the vaccination campaign amid the havoc of the Corona virus. On Saturday, the first consignment of Russian corona virus Sputnik-V also arrived in the country, which could soon be used in the vaccination campaign. Expressing happiness over Sputnik-V reaching India, Russian Ambassador to India Nikolay Kudashev said that its production in India is also going to start soon and it will be gradually increased to 85 million rupees per year. Let us know that the first consignment of Russian vaccine has reached Hyderabad in Telangana this afternoon.
The Russian ambassador further said, “It is a pleasure to say that the first batch of Sputnik-V was delivered in Hyderabad today. As Russia and India continue their dedicated joint effort to counter Corona, the move will be particularly important to support the Indian government’s efforts to reduce the deadly second wave. “The Russian ambassador also Said that this vaccine has the highest affixation as compared to other vaccines in the world and it will prove to be effective in new strains as well.
He said, “Its local production is going to start soon and there are plans to make 85 crore doses per year. We look forward to expanding our bilateral and multilateral cooperation with India to prevent the epidemic. ”Last month, the Drug Controller General (DCGI) asked Dr. Reddy Laboratories to introduce Russian vaccine Sputnik-V for emergency use. Was allowed to be imported. It is believed that the Russian vaccine can be used for the vaccination campaign for people over 18 years of age in the country, which started from May 1.
For the first time in the last 24 hours, more than four lakh new cases of corona virus have been reported in the country. This is by far the largest number of patients exposed to a single day in any country since the onset of the epidemic. There is a strong emphasis on vaccine prevention of corona in India. So far more than 15 and a half million people have been vaccinated. This vaccine from Russia will be the third vaccine to be used in the country. Earlier in January, DCGI had approved the emergency use of Covishield of Serum Institute of India and Kovaxin of Bharat Biotech.